ArticleFrontiers in pharmacology2023

Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China.

Shixian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.